Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
The current Amgen(AMGN) stock price is $407.76, with a market capitalization of 220.45B. The stock trades at a price-to-earnings (P/E) ratio of 25.48 and offers a dividend yield of 2.42%.
On 2026-09-23, Amgen(AMGN) stock traded between a low of $404.34 and a high of $415.58. Shares are currently priced at $407.76, which is +0.8% above the low and -1.9% below the high.
The Amgen(AMGN)'s current trading volume is 1.11M, compared to an average daily volume of 3.47M.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
In the last year, Amgen(AMGN) shares hit a 52-week high of $447.03 and a 52-week low of $269.77.
AMGN News
In recent trading, shares of Amgen Inc (Symbol: AMGN) have crossed above the average analyst 12-month target price of $239.88, changing hands for $241.01/share....
Salveen Richter, an analyst from Goldman Sachs, maintained the Buy rating on Amgen. The associated price target remains the same with $450.00. Salveen Richter...
...
Analyst ratings
53%
of 36 ratingsMore AMGN News
Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Sell rating on Amgen. The associated price target remains the same with $317.00. Tazeen...
Amgen (AMGN) has become a focal point for autoimmune investors after releasing Phase 3 data showing its experimental drug dazodalibep met the primary endpoint i...
Citi says Amgen’s (AMGN) dazodalibep delivered “positive” Phase 3 results in systemic Sjogren’s, which reduces clinical risk for “a potentially underappreciated...
Technology Amgen Boasts Success In Sjogren's; Shares Charge Ahead Licensing Amgen (AMGN) stock bounded above its 50-day line Tuesday after publishing promising...
Amgen (AMGN) announced positive topline results from the Phase 3 OASIZ 301 study evaluating dazodalibep in adults with Sjogren’s disease and moderate-to-severe...
Investing Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story? Both Amgen and Merck write quarterly checks and raise them every year, but onl...
Amgen reported that the FDA approved a significant update to IMDELLTRA's U.S. prescribing information, reducing the recommended monitoring after the first two i...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.